Work

B09 The CANOPY Program: Three Phase 3 Studies Evaluating Canakinumab in Patients with Non-Small Cell Lung Cancer (NSCLC)

Year: 2020

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.12.078

Authors: E.B. Garon, A. Ardizzoni, F. Barlesi, B.C. Cho, G. de Castro, E. Felip, Y. Goto, A. Greystoke, S. Lu, D.W.-T. Lim, M. Reck, B.J. Solomon, D.R. Spigel, D.S.W. Tan, M. Thomas, J.C.-H. Yang, B.E. Johnson

Institutions: University of California, Los Angeles, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Aix-Marseille Université, Yonsei University, Instituto do Câncer do Estado de São Paulo, Vall d'Hebron Institute of Oncology, National Cancer Center Hospital, Newcastle upon Tyne Hospital, Shanghai Jiao Tong University, Shanghai Chest Hospital, National Cancer Centre Singapore, German Center for Lung Research, Peter MacCallum Cancer Centre, Sarah Cannon, Heidelberg University, University Hospital Heidelberg, National Taiwan University, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3002803103

Cites:

Cited by:

Related to: 10